GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (STU:BJX1) » Definitions » Marketable Securities

BioLife Solutions (STU:BJX1) Marketable Securities : €20.01 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is BioLife Solutions Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. BioLife Solutions's Marketable Securities for the quarter that ended in Mar. 2025 was €20.01 Mil.

BioLife Solutions's annual Marketable Securities declined from Dec. 2022 (€40.84 Mil) to Dec. 2023 (€14.94 Mil) and declined from Dec. 2023 (€14.94 Mil) to Dec. 2024 (€8.78 Mil).


BioLife Solutions Marketable Securities Historical Data

The historical data trend for BioLife Solutions's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Marketable Securities Chart

BioLife Solutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 40.84 14.94 8.78

BioLife Solutions Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.33 11.26 9.20 8.78 20.01

BioLife Solutions Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


BioLife Solutions  (STU:BJX1) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


BioLife Solutions Marketable Securities Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLife Solutions Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines